News

Article

Pharmaceutical Technology's In the Lab eNewsletter

In the Lab eNewsletter

Pharmaceutical Technology\'s In the Lab eNewsletter-07-02-2019
Volume14
Issue 7

Aptar Acquires Nanopharm and Gateway Analytical

The acquisitions, totaling $50 million, are expected expand Aptar Pharma’s service offerings to support complex product development.

On June 10, 2019, AptarGroup announced that it has acquired two pharmaceutical services companies, Nanopharm and Gateway Analytical, for a combined price of approximately $50 million.

Nanopharm, located in Newport, UK, is a provider of orally inhaled and nasal drug product design and development services. Gateway Analytical, located in Gibsonia, PA, provides particulate detection and predictive analytical services to customers developing injectable medicines.

Both acquisitions bring complementary analytical, testing, and development services for all stages of drug development and commercialization. The acquisitions are part of Aptar’s strategy to broaden its service portfolio to support complex product development. Aptar states that the expanded services platform will enable its pharma arm to collaborate earlier with customers to support their complex drug formulations and delivery requirements.

“We are delighted to welcome the talented teams of Nanopharm and Gateway and their customers to Aptar Pharma,” commented Gael Touya, president of Aptar Pharma, in a company press release. “Their expertise and capabilities will deepen our current range of services offered to customers who are developing and testing inhaled and injected medicines. This enables us to participate in a broader spectrum of the pre-clinical, clinical trial, and market-launch phases of drug development.”

Source: AptarGroup

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content